The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome

European Journal of Nutrition

Volumn 55, Issue 8, 2016, Pages 2357-2364

  Raygan, Fariba ^a   Rezavandi, Zohreh ^a   Dadkhah Tehrani, Sahar ^a   Farrokhian, Alireza ^a   Asemi, Zatollah ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coenzyme Q10; Coronary heart disease; Metabolic syndrome; Supplementation; Type 2 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLACEBO; TRIACYLGLYCEROL; UBIDECARENONE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; NITRIC OXIDE; UBIQUINONE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL OUTCOME; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET CELL FUNCTION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; CALORIC INTAKE; DIETARY SUPPLEMENT; DRUG EFFECTS; HOMEOSTASIS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENERGY INTAKE; GLUTATHIONE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALONDIALDEHYDE; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE; OBESITY; OXIDATIVE STRESS; UBIQUINONE;

EID: 84942013928     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-1042-7     Document Type: Article

References (33)

1. Miles MV, Morrison JA, Horn PS, Tang PH, Pesce AJ (2004) Coenzyme Q10 changes are associated with metabolic syndrome. Clin Chim Acta 344(1–2):173–179
2. Chokrungvaranon N, Deer J, Reaven PD (2011) Intensive glycemic control and cardiovascular disease: are there patients who may benefit? Postgrad Med 123(6):114–123
3. Sivitz WI, Yorek MA (2010) Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 12(4):537–577
4. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54(6):1615–1625
5. Fiorentino TV, Prioletta A, Zuo P, Folli F (2013) Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 19(32):5695–5703
6. Suksomboon N, Poolsup N, Juanak N (2015) Effects of coenzyme Q supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. J Clin Pharm Ther 40(4):413–418
7. Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Fernandez Vega A, de la Mata M, Delgado Pavon A, de Miguel M, Perez Calero C, Villanueva Paz M, Cotán D, Sánchez-Alcázar JA (2014) Coenzyme q10 therapy. Mol Syndromol 5(3–4):187–197
8. Miyake Y, Shouzu A, Nishikawa M, Yonemoto T, Shimizu H, Omoto S, Hayakawa T, Inada M (1999) Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients. Arzneimittelforschung 49(4):324–329
9. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD (2002) Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 56(11):1137–1142
10. Lee BJ, Huang YC, Chen SJ, Lin PT (2012) Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition 28(3):250–255
11. Lee BJ, Huang YC, Chen SJ, Lin PT (2012) Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition 28(7–8):767–772
12. Lee YJ, Cho WJ, Kim JK, Lee DC (2011) Effects of coenzyme Q10 on arterial stiffness, metabolic parameters, and fatigue in obese subjects: a double-blind randomized controlled study. J Med Food 14(4):386–390
13. Amin MM, Asaad GF, Abdel Salam RM, El-Abhar HS, Arbid MS (2014) Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PLoS ONE 9(2):e89169
14. Carmona MC, Lefebvre P, Lefebvre B, Galinier A, Benani A, Jeanson Y, Louche K, Flajollet S, Ktorza A, Dacquet C, Pénicaud L, Casteilla L (2009) Coadministration of coenzyme Q prevents rosiglitazone-induced adipogenesis in ob/ob mice. Int J Obes (Lond) 33(2):204–211
15. Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Doring F (2008) Functions of coenzyme Q10 in inflammation and gene expression. BioFactors 32(1–4):179–183
16. Farhangi MA, Alipour B, Jafarvand E, Khoshbaten M (2014) Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. Arch Med Res 45(7):589–595
17. Welles CC, Whooley MA, Karumanchi SA, Hod T, Thadhani R, Berg AH, Ix JH, Mukamal KJ (2014) Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol 179(11):1279–1287
18. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT (2013) Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 36(4):845–853
19. Tatsch E, Bochi GV, Pereira Rda S, Kober H, Agertt VA, de Campos MM, Gomes P, Duarte MM, Moresco RN (2011) A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clin Biochem 44(4):348–350
20. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239(1):70–76
21. Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105(5):581–584
22. Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9(6):515–540
23. Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A (2014) Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 33(2):198–203
24. Park E (2010) Birth weight was negatively correlated with plasma ghrelin, insulin resistance, and coenzyme Q10 levels in overweight children. Nutr Res Pract 4(4):311–316
25. Mehmetoglu I, Yerlikaya FH, Kurban S (2011) Correlation between vitamin A, E, coenzyme Q(10) and degree of insulin resistance in obese and non-obese subjects. J Clin Biochem Nutr 49(3):159–163
26. Kolahdouz Mohammadi R, Hosseinzadeh-Attar MJ, Eshraghian MR, Nakhjavani M, Khorami E, Esteghamati A (2013) The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients. Minerva Gastroenterol Dietol 59(2):231–236
27. Gokbel H, Gergerlioglu HS, Okudan N, Gul I, Buyukbas S, Belviranli M (2010) Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men. J Med Food 13(1):216–218
28. Lee BJ, Tseng YF, Yen CH, Lin PT (2013) Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J 12(1):142. doi:10.1186/1475-2891-12-142
29. Diaz-Castro J, Guisado R, Kajarabille N, Garcia C, Guisado IM, de Teresa C, Ochoa JJ (2012) Coenzyme Q(10) supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise. Eur J Nutr 51(7):791–799
30. Mancini A, Milardi D, Bianchi A, Festa R, Silvestrini A, De Marinis L, Pontecorvi A, Meucci E (2007) Increased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysis. Arch Androl 53(1):37–42
31. Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V (2002) Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 45(3):420–426
32. Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20(6):591–598
33. Arroyo A, Kagan VE, Tyurin VA, Burgess JR, de Cabo R, Navas P, Villalba JM (2000) NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane. Antioxid Redox Signal 2(2):251–262